View Information Collection Request (ICR) Package

Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 0920-0307	ICR Reference No: 201805-0920-005
Status: Historical Active	Previous ICR Reference No: 201512-0920-005
Agency/Subagency: HHS/CDC	Agency Tracking No:
Title: Gonococcal Isolate Surveillance Project
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/20/2018
	Date Received in OIRA: 07/20/2018
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2021	36 Months From Approved	02/28/2019
Responses	26,592	0	14,700
Time Burden (Hours)	11,376	0	8,628
Cost Burden (Dollars)	226,117	0	0

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	26,592	14,700	11,892
Annual Time Burden (Hours)	11,376	8,628	2,748
Annual Cost Burden (Dollars)	226,117	0	226,117

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: There is no change in burden for 20 sentinel sites that will continue to conduct core surveillance. There is an increase in burden for 10 sentinel sites that will begin collecting additional data and specimens for enhanced surveillance. Enhanced surveillance will increase the number of isolates submitted for antimicrobial resistance testing. Measures have been taken to decrease the burden per response, but there is a net increase in burden. There is a decrease in burden associated with control strain susceptibility testing.

Annual Cost to Federal Government: $1,176,900

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Renita Macaluso 770 488-6458 arp5@cdc.gov

Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.